nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—Fibromyalgia—Hydrochlorothiazide—nephrolithiasis	0.0611	0.0888	CcSEcCtD
Esomeprazole—ATP4B—Ion channel transport—CLCN4—nephrolithiasis	0.0316	0.106	CbGpPWpGaD
Esomeprazole—ATP4B—Ion channel transport—CLCN5—nephrolithiasis	0.0316	0.106	CbGpPWpGaD
Esomeprazole—Oral disorder—Hydrochlorothiazide—nephrolithiasis	0.0303	0.0441	CcSEcCtD
Esomeprazole—ATP4A—Ion channel transport—CLCN4—nephrolithiasis	0.0281	0.0941	CbGpPWpGaD
Esomeprazole—ATP4A—Ion channel transport—CLCN5—nephrolithiasis	0.0281	0.0941	CbGpPWpGaD
Esomeprazole—Leg pain—Hydrochlorothiazide—nephrolithiasis	0.0166	0.0241	CcSEcCtD
Esomeprazole—Epigastric pain—Hydrochlorothiazide—nephrolithiasis	0.0158	0.023	CcSEcCtD
Esomeprazole—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.0146	0.0212	CcSEcCtD
Esomeprazole—Sleep disturbance—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0199	CcSEcCtD
Esomeprazole—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0173	CcSEcCtD
Esomeprazole—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0165	CcSEcCtD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.011	0.0367	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.011	0.0367	CbGpPWpGaD
Esomeprazole—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.01	0.0145	CcSEcCtD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00979	0.0327	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00979	0.0327	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00979	0.0327	CbGpPWpGaD
Esomeprazole—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00945	0.0137	CcSEcCtD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00895	0.0299	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00895	0.0299	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00872	0.0292	CbGpPWpGaD
Esomeprazole—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00848	0.0123	CcSEcCtD
Esomeprazole—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.00826	0.012	CcSEcCtD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00798	0.0267	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00798	0.0267	CbGpPWpGaD
Esomeprazole—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.0078	0.0113	CcSEcCtD
Esomeprazole—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.007	0.0102	CcSEcCtD
Esomeprazole—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00693	0.0101	CcSEcCtD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00678	0.0227	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00678	0.0227	CbGpPWpGaD
Esomeprazole—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00642	0.00933	CcSEcCtD
Esomeprazole—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00633	0.0092	CcSEcCtD
Esomeprazole—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00633	0.0092	CcSEcCtD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00631	0.0211	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00631	0.0211	CbGpPWpGaD
Esomeprazole—Swelling—Hydrochlorothiazide—nephrolithiasis	0.0063	0.00916	CcSEcCtD
Esomeprazole—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00627	0.00912	CcSEcCtD
Esomeprazole—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00622	0.00903	CcSEcCtD
Esomeprazole—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00616	0.00895	CcSEcCtD
Esomeprazole—Injury—Hydrochlorothiazide—nephrolithiasis	0.00605	0.00879	CcSEcCtD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00605	0.0202	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00605	0.0202	CbGpPWpGaD
Esomeprazole—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00594	0.00864	CcSEcCtD
Esomeprazole—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00592	0.0086	CcSEcCtD
Esomeprazole—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00589	0.00856	CcSEcCtD
Esomeprazole—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00587	0.00853	CcSEcCtD
Esomeprazole—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00584	0.00849	CcSEcCtD
Esomeprazole—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00584	0.00849	CcSEcCtD
Esomeprazole—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00577	0.00838	CcSEcCtD
Esomeprazole—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00572	0.00831	CcSEcCtD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00562	0.0188	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00562	0.0188	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00562	0.0188	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00562	0.0188	CbGpPWpGaD
Esomeprazole—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00558	0.00811	CcSEcCtD
Esomeprazole—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00556	0.00808	CcSEcCtD
Esomeprazole—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00556	0.00808	CcSEcCtD
Esomeprazole—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00547	0.00795	CcSEcCtD
Esomeprazole—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00537	0.0078	CcSEcCtD
Esomeprazole—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00521	0.00757	CcSEcCtD
Esomeprazole—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.0051	0.00741	CcSEcCtD
Esomeprazole—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00508	0.00738	CcSEcCtD
Esomeprazole—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00506	0.00735	CcSEcCtD
Esomeprazole—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00502	0.0073	CcSEcCtD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00501	0.0168	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00501	0.0168	CbGpPWpGaD
Esomeprazole—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00501	0.00728	CcSEcCtD
Esomeprazole—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00501	0.00728	CcSEcCtD
Esomeprazole—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00501	0.00728	CcSEcCtD
Esomeprazole—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00492	0.00715	CcSEcCtD
Esomeprazole—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.0049	0.00713	CcSEcCtD
Esomeprazole—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0049	0.00713	CcSEcCtD
Esomeprazole—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00484	0.00703	CcSEcCtD
Esomeprazole—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00481	0.00698	CcSEcCtD
Esomeprazole—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00481	0.00698	CcSEcCtD
Esomeprazole—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00471	0.00685	CcSEcCtD
Esomeprazole—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00468	0.0068	CcSEcCtD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00449	0.015	CbGpPWpGaD
Esomeprazole—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00449	0.00653	CcSEcCtD
Esomeprazole—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00449	0.00653	CcSEcCtD
Esomeprazole—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00447	0.00649	CcSEcCtD
Esomeprazole—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00444	0.00645	CcSEcCtD
Esomeprazole—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00443	0.00643	CcSEcCtD
Esomeprazole—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00439	0.00637	CcSEcCtD
Esomeprazole—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00437	0.00636	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00425	0.00617	CcSEcCtD
Esomeprazole—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00421	0.00612	CcSEcCtD
Esomeprazole—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00418	0.00607	CcSEcCtD
Esomeprazole—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00416	0.00605	CcSEcCtD
Esomeprazole—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00416	0.00605	CcSEcCtD
Esomeprazole—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00409	0.00594	CcSEcCtD
Esomeprazole—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00404	0.00587	CcSEcCtD
Esomeprazole—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00402	0.00584	CcSEcCtD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00401	0.0134	CbGpPWpGaD
Esomeprazole—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.004	0.00581	CcSEcCtD
Esomeprazole—CYP2C19—urine—nephrolithiasis	0.00398	0.307	CbGeAlD
Esomeprazole—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00569	CcSEcCtD
Esomeprazole—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00386	0.0056	CcSEcCtD
Esomeprazole—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00385	0.00559	CcSEcCtD
Esomeprazole—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00383	0.00556	CcSEcCtD
Esomeprazole—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00382	0.00555	CcSEcCtD
Esomeprazole—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00379	0.00551	CcSEcCtD
Esomeprazole—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00371	0.00539	CcSEcCtD
Esomeprazole—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00364	0.00528	CcSEcCtD
Esomeprazole—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00359	0.00521	CcSEcCtD
Esomeprazole—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00357	0.00519	CcSEcCtD
Esomeprazole—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.0034	0.00494	CcSEcCtD
Esomeprazole—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.0033	0.00479	CcSEcCtD
Esomeprazole—Tension—Hydrochlorothiazide—nephrolithiasis	0.00329	0.00477	CcSEcCtD
Esomeprazole—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00328	0.00476	CcSEcCtD
Esomeprazole—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00325	0.00473	CcSEcCtD
Esomeprazole—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00324	0.00471	CcSEcCtD
Esomeprazole—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00322	0.00468	CcSEcCtD
Esomeprazole—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00316	0.00459	CcSEcCtD
Esomeprazole—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00314	0.00456	CcSEcCtD
Esomeprazole—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00311	0.00451	CcSEcCtD
Esomeprazole—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00309	0.0045	CcSEcCtD
Esomeprazole—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00308	0.00447	CcSEcCtD
Esomeprazole—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00306	0.00445	CcSEcCtD
Esomeprazole—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00302	0.00439	CcSEcCtD
Esomeprazole—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00301	0.00437	CcSEcCtD
Esomeprazole—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.003	0.00436	CcSEcCtD
Esomeprazole—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00296	0.0043	CcSEcCtD
Esomeprazole—Cough—Hydrochlorothiazide—nephrolithiasis	0.00292	0.00425	CcSEcCtD
Esomeprazole—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00285	0.00414	CcSEcCtD
Esomeprazole—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00285	0.00414	CcSEcCtD
Esomeprazole—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00285	0.00414	CcSEcCtD
Esomeprazole—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00284	0.00413	CcSEcCtD
Esomeprazole—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00282	0.00409	CcSEcCtD
Esomeprazole—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00279	0.00405	CcSEcCtD
Esomeprazole—ATP4A—renal system—nephrolithiasis	0.00279	0.215	CbGeAlD
Esomeprazole—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00276	0.004	CcSEcCtD
Esomeprazole—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00273	0.00397	CcSEcCtD
Esomeprazole—ATP4A—kidney—nephrolithiasis	0.00269	0.208	CbGeAlD
Esomeprazole—Shock—Hydrochlorothiazide—nephrolithiasis	0.00269	0.00391	CcSEcCtD
Esomeprazole—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00268	0.00389	CcSEcCtD
Esomeprazole—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00267	0.00388	CcSEcCtD
Esomeprazole—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00264	0.00384	CcSEcCtD
Esomeprazole—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0026	0.00379	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00249	0.00362	CcSEcCtD
Esomeprazole—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00247	0.00359	CcSEcCtD
Esomeprazole—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00357	CcSEcCtD
Esomeprazole—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00244	0.00354	CcSEcCtD
Esomeprazole—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00243	0.00353	CcSEcCtD
Esomeprazole—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00241	0.0035	CcSEcCtD
Esomeprazole—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00238	0.00345	CcSEcCtD
Esomeprazole—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00236	0.00342	CcSEcCtD
Esomeprazole—CYP3A4—urine—nephrolithiasis	0.00235	0.182	CbGeAlD
Esomeprazole—Pain—Hydrochlorothiazide—nephrolithiasis	0.00234	0.0034	CcSEcCtD
Esomeprazole—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00234	0.0034	CcSEcCtD
Esomeprazole—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00225	0.00327	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00223	0.00325	CcSEcCtD
Esomeprazole—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00217	0.00315	CcSEcCtD
Esomeprazole—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00216	0.00314	CcSEcCtD
Esomeprazole—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00216	0.00314	CcSEcCtD
Esomeprazole—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00201	0.00293	CcSEcCtD
Esomeprazole—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.00199	0.00666	CbGpPWpGaD
Esomeprazole—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00196	0.00285	CcSEcCtD
Esomeprazole—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00193	0.00281	CcSEcCtD
Esomeprazole—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00187	0.00272	CcSEcCtD
Esomeprazole—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00181	0.00263	CcSEcCtD
Esomeprazole—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00174	0.00252	CcSEcCtD
Esomeprazole—Rash—Hydrochlorothiazide—nephrolithiasis	0.00172	0.0025	CcSEcCtD
Esomeprazole—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00172	0.0025	CcSEcCtD
Esomeprazole—Headache—Hydrochlorothiazide—nephrolithiasis	0.00171	0.00249	CcSEcCtD
Esomeprazole—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00162	0.00236	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.0012	0.004	CbGpPWpGaD
Esomeprazole—CYP3A4—renal system—nephrolithiasis	0.000575	0.0445	CbGeAlD
Esomeprazole—CYP3A4—kidney—nephrolithiasis	0.000556	0.043	CbGeAlD
Esomeprazole—CYP2C19—Metabolism—GRHPR—nephrolithiasis	0.000449	0.0015	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AGXT—nephrolithiasis	0.0004	0.00134	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APRT—nephrolithiasis	0.00034	0.00114	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	0.00034	0.00114	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.00027	0.000904	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AQP1—nephrolithiasis	0.000243	0.000811	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000241	0.000805	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CHRM3—nephrolithiasis	0.000219	0.000734	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000205	0.000685	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000205	0.000685	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AQP1—nephrolithiasis	0.000146	0.000488	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CHRM3—nephrolithiasis	0.000132	0.000441	CbGpPWpGaD
